OTTO Fuel I1 (OFII) is a propellent used by the United States Navy in its Mk 46 and Mk 48 torpedoes. Owing to the possibility of human exposure during fueling and defueling operations, studies were initiated to determine if OF11 was a developmental toxin. Phase I of the investigation involved dosing
Developmental Toxicity of JP-8 Jet Fuel in the Rat
β Scribed by James R. Cooper; David R. Mattie
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 324 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0260-437X
No coin nor oath required. For personal study only.
β¦ Synopsis
JP-8 aviation fuel is being phased in as a replacement for both JP-4 and JP-5 jet fuels presently in use by the Air Force and Navy, respectively. At the present time, 11% of active-duty Air Force personnel are women of child-bearing age. This study was undertaken to determine the threat posed to the unborn fetus should female active-duty personnel come in contact with JP-8 while pregnant. Time-mated Sprague-Dawley rats were dosed orally with JP-8 at 0, 500, 1000, 1500 and 2000 mg kg-' day-' on days 6-15 of pregnancy. The number and type of fetal malformations and variations observed did not differ significantly between dose groups. Dams in the 1000, 1500 and 2000 mg kg-' day-' groups gained significantly less body weight during pregnancy than did control dams. Embryo toxicity was indicated by a significant reduction in fetal body weight in the 1500 and 2000 mg kg-' day-' dose groups.
π SIMILAR VOLUMES
In a simulated military flightline exposure protocol, Fischer 344 rats (F344) were used to investigate the pulmonary effects of JP-8 jet fuel inhalation. Exposures were nose only and for 1 h daily, Groups were exposed for 7 days (7D) or 28 days (28D). Each exposure group had a matched longitudinal c
## Abstract Dermal absorption of JPβ8 jet fuel can lead to skin irritation within hours after exposure. This study detected the formation of oxidative species and lowβmolecularβweight DNA in rat skin as potential indicators of JPβ8βinduced skin injury. At 0, 1, 2, 4 and 6 h after the beginning of a
Caprolactam was evaluated for developmental toxicity potential in both rats and rabbits by the oral route. In rats dosed on days 6-15 of gestation with 100,500 or 1000 mg/kg/day of caprolactam, the maternal survival rate was significantly lower in the high-dose group and implantation efficiencies we